SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin inches up on reporting 74% rise in Q2 consolidated net profit

08 Nov 2024 Evaluate

Lupin is currently trading at Rs. 2110.75, up by 0.20 points or 0.01% from its previous closing of Rs. 2110.55 on the BSE.

The scrip opened at Rs. 2144.00 and has touched a high and low of Rs. 2154.00 and Rs. 2080.00 respectively. So far 115331 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2312.00 on 05-Sep-2024 and a 52 week low of Rs. 1153.55 on 13-Nov-2023.

Last one week high and low of the scrip stood at Rs. 2217.50 and Rs. 2080.00 respectively. The current market cap of the company is Rs. 96220.63 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 46.60% and 6.44% respectively.

Lupin has reported 47.24% rise in its net profit at Rs 807.76 crore for the quarter ended September 30, 2024 as compared to Rs 548.61 crore for the same quarter in the previous year. Total income of the company increased by 12.32% at Rs 4138.82 crore for Q2FY25 as compared to Rs 3684.83 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported rise of 73.52% in net profit at Rs 859.48 crore for Q2FY25 as compared to Rs 495.32 crore for the same quarter in the previous year. Total income of the company increased by 12.52% at Rs 5715.02 crore for Q2FY25 as compared to Rs 5078.96 crore for the corresponding quarter previous year.


Lupin Share Price

2442.35 98.95 (4.22%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×